
Attendees included Datuk Noripah Kamso, Senior Independent Non-Executive Director of DXN Holdings Bhd; Amirah Khairiah Abdul Latip, District Officer of Kubang Pasu; Dr. Haim Hilman Abdullah, Kedah State Executive Councillor; Dato’ Dr. Nadzman Mustaffa, Kedah State Financial Officer; Kedah Chief Minister Dato’ Seri Haji Muhammad Sanusi Md Nor; DXN Executive Chairman and Founder Datuk Lim Siow Jin; PKNK CEO Dato’ Haji Mohd Sahil Zabidi; Kubang Pasu Municipal Council President Junaidi Abdul Rani; DXN COO Abdul Hafiz Mahmood Hisham; CFO Lim Beng Cheng; and CTO Muhammad Luthfi Hidayat.
DXN Holdings Bhd. (“DXN” or the “Company”) , a leading global wellness company and manufacturer of nutraceutical products, broke ground on Malaysia’s largest nutraceutical manufacturing facility in Bukit Kayu Hitam, Kedah (“BKH Facility”), a RM140 million investment that cements Malaysia’s position as the anchor of DXN’s global manufacturing network and strengthens the Group’s long-term growth platform.
The ceremony was officiated by YAB Dato’ Seri Haji Muhammad Sanusi bin Md Nor, Menteri Besar of Kedah, accompanied by Datuk Lim Siow Jin, Founder and Executive Chairman of DXN.
Phase 1 of the development will feature approximately 300,000 square feet (“sq ft”) of built-up space across a 26.6-acre site leased from Perbadanan Kemajuan Negeri Kedah (“PKNK”). The integrated manufacturing hub will house 7 production blocks, 10 warehouse facilities and a dedicated Research and Development centre, making it DXN’s largest facility worldwide and one of Malaysia’s largest nutraceutical manufacturing complexes.
Production is targeted to commence in March 2028 with 118 SKUs across Coffee, Food & Beverage and Juice categories, while future phases will support expansion into higher-value segments such as Cosmetics, Personal Care and Pharmaceuticals.
The investment comes as DXN continues to experience sustained growth across its international markets. Over the past three years, the Group has delivered consistent expansion in revenue and earnings, increasing demand on its manufacturing and logistics infrastructure. The BKH Facility is designed to provide the capacity, flexibility and operational resilience required to support DXN’s next phase of global growth while ensuring that manufacturing capability remains ahead of future demand.

The BKH Facility will complement and expand DXN’s existing manufacturing footprint by providing a scalable platform for production, warehousing and research, while improving operational flexibility and strengthening supply chain resilience. Beyond capacity expansion, the facility is expected to deliver efficiency gains through greater automation, integrated logistics capabilities and the consolidation of key manufacturing and warehousing functions within a single campus, positioning DXN to support growing global demand more effectively over the long term.
Welcoming the investment, Menteri Besar of Kedah YAB Dato’ Seri Haji Muhammad Sanusi bin Md Nor said:
“On behalf of the Kedah State Government and the people of Kedah, I congratulate DXN on this historic investment. Malaysia’s largest nutraceutical factory will be built right here in Kedah, and that is a source of great pride for our State. This RM140 million commitment creates quality employment for our people, strengthens Kedah’s position as a premier industrial destination within the Northern Corridor, and demonstrates the confidence that world-class manufacturers continue to place in Kedah as a foundation for global operations. DXN has been a trusted partner of Kedah for over 20 years. Today, that partnership enters a new and historic chapter.”
Datuk Lim Siow Jin, Executive Chairman and Founder of DXN pointed to the structural resilience of the global nutraceutical and wellness industry as the foundation underpinning the investment.
“DXN’s revenue has grown at a compounded annual growth rate of 15.4% over the past three years, and FY2025 delivered all-time highs in revenue, net profit and EBITDA. That growth has outpaced our existing production capacity.”
“Bukit Kayu Hitam is our answer, with seven production blocks and a dedicated R&D centre, built to support the next decade of growth. More than a factory, it is a purpose-built manufacturing, logistics and innovation hub that will enable DXN to scale more efficiently, operate more effectively and serve our global markets with greater flexibility and resilience.
Together with our existing facilities in Kedah, it will further reinforce Malaysia’s role as the heart of our global production ecosystem and strengthen our ability to support customers worldwide.”
Datuk Lim pointed to the structural resilience of the global nutraceutical and wellness industry as the foundation underpinning the investment.
“The global health and wellness market is growing at a pace that most investors have yet to fully appreciate. The ready-to-eat and functional food segment alone is projected to reach RM1.6 trillion by 2034, growing at 7.7% annually. Wellness spending per capita in Asia stands at just RM1,860 per year compared to RM23,815 in North America and RM7,410 in Europe; that convergence gap represents decades of addressable growth. DXN currently generates RM1.9 billion in annual revenue from a global market measured in the hundreds of billions. Bukit Kayu Hitam is how we ensure our production capacity is never the constraint on capturing that opportunity.”
Bukit Kayu Hitam is the flagship of DXN’s Global Manufacturing Strategy, which targets 21 factories across four continents by 2028. The facility anchors a three-pillar Malaysian manufacturing ecosystem alongside the existing Jitra complex and the Gua Musang facility under development in Kelantan.
Together, this integrated cluster will supply the majority of DXN’s global SKU portfolio to its consumer community of approximately 22 million registered consumers across more than 180 countries, while new regional facilities in Peru, Bolivia, Morocco, Saudi Arabia and Brazil serve their respective local markets.
The RM140 million investment will be financed through external funding facilities, underpinned by the Group’s robust financial position, including a zero net debt balance sheet and a debt-to-equity ratio of approximately 0.15 times. This provides DXN with the financial flexibility to pursue strategic growth initiatives while maintaining a disciplined approach to capital allocation and long-term value creation.
From Kedah to the world, the BKH Facility reflects DXN’s confidence in Malaysia as its manufacturing home base and its commitment to building a world-class production platform capable of supporting future growth across global markets. The project represents a significant milestone in DXN’s journey to strengthen its global manufacturing network and deliver trusted health and wellness products to consumers worldwide for decades to come.


